| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |